Bioreactor– tag –
-
Century Therapeutics Seeks Director to Lead Large-Scale Cell Therapy Process Development for Clinical and Commercial Programs
JobLeads (Century Therapeutics, Inc.) USA Overview Century Therapeutics is recruiting a Director of Large-Scale Process Development to lead scale-up strategies for bioreactor expansion, harvesting, and fill/finish operations in their cli... -
REPROCELL Publishes Article on Scaling iPSC Manufacturing: Addressing Challenges from Cell Line Development to Clinical Production
REPROCELL Japan Overview REPROCELL has published an article titled "Scaling iPSC Manufacturing: From Cell Line Development to Clinical Production," focusing on the crucial aspects of industrializing induced pluripotent stem cell (iPSC) t... -
Upside Foods Withdraws $50M Bid for Believer Meats’ US Facility, Signaling Strategic Re-evaluation Amidst Industry Consolidation
AgFunderNews USA Overview US cultivated meat startup Upside Foods has withdrawn its $50 million bid to acquire the shuttered North Carolina facility of former competitor Believer Meats, yet confirmed its continued interest. The facility ... -
Integration of Digital Twins, AI, PAT, and IoT Revolutionizes Single-Use Mixing Solutions in Bioprocess Engineering for Enhanced Robustness
Facebook Global Overview In bioprocess engineering, the selection of single-use mixing solutions is significantly advanced by integrating digital twin technology, AI/machine learning (ML), Process Analytical Technology (PAT), IoT, and so... -
Drastic Cost Reduction in Biosimilar Manufacturing: Integrated Strategies of Continuous Bioprocessing, QbD, Single-Use Systems, and AI
Pharma Advancement USA Overview Integrated strategies including continuous bioprocessing with high-density cell culture, Quality by Design (QbD) with Process Analytical Technology (PAT), single-use systems with modular facility design, a... -
REPROCELL Enables Clinical-Scale iPSC Manufacturing with StemEdit and Bioreactor Technologies
REPROCELL Japan Overview REPROCELL is facilitating a seamless transition from lab-scale iPSC manufacturing to GMP production and clinical application by integrating its StemEdit gene-editing platform with ABLE Biott and BioThrust bioreac... -
Synthego Highlights CRISPR’s Potential to Drastically Improve Cultivated Meat Production Efficiency
Synthego USA Overview Synthego emphasizes the transformative potential of CRISPR gene-editing technology in significantly enhancing the efficiency of cultivated meat production, addressing critical challenges like high costs and scalabil... -
AI-Guided 3D Bioreactors Revolutionize iPSC Manufacturing: Scaling Up and Cutting Costs for Accelerated Commercialization
Wiley Analytical Science USA Overview AI-guided 3D bioreactor technology is revolutionizing iPSC manufacturing, enabling reliable, efficient, and scalable production of pluripotent stem cells (PSCs). This innovative platform facilitates ... -
Commercial-Scale iPSC Cell Therapy Production Gains Traction with US Clinical Trial Progress and Master Cell Bank Establishment
The Medicine Maker UK Overview Manufacturing challenges for commercial-scale iPSC cell therapies are being overcome, with multiple iPSC clinical trials progressing in the U.S. for indications like Type 1 Diabetes, Parkinson's disease, an... -
REPROCELL Pioneers Integrated iPSC Manufacturing Platform, Accelerating US Phase III Clinical Programs with AI-Enhanced Gene Editing and GMP Compliance
REPROCELL Japan Overview REPROCELL has launched a comprehensive iPSC manufacturing platform designed to accelerate the clinical development of iPSC-derived therapeutics, notably supporting a US Phase III program. The platform integrates ...
